Literature DB >> 22653180

[Antiperspirants for the therapy of focal hyperhidrosis].

M Streker1, M Kerscher.   

Abstract

In Europe often no clear distinction is made between deodorant and antiperspirant. Particularly in Germany, the labeling "deo" is used for both. Only antiperspirants are capable of influencing the activity of eccrine sweat glands. In the treatment of focal hyperhidrosis, the use of aluminum chloride solutions represents the first choice. The efficacy is well documented in a variety of studies. Subjective side effects include pruritus and - less often - irritant dermatitis, which can be treated symptomatically and usually does not require discontinuation of the treatment. Rare variants of focal hyperhidrosis like auriculotemporal syndrome, Ross syndrome and nevus sudoriferus also are suitable for treatment with topical aluminum chloride hexahydrate solutions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22653180     DOI: 10.1007/s00105-012-2330-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  11 in total

Review 1.  Topical pharmacological treatment.

Authors:  Erhard Hölzle
Journal:  Curr Probl Dermatol       Date:  2002

Review 2.  Recognition, diagnosis, and treatment of primary focal hyperhidrosis.

Authors:  John Hornberger; Kevin Grimes; Markus Naumann; Dee Anna Glaser; Nicholas J Lowe; Hans Naver; Samuel Ahn; Lewis P Stolman
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

3.  Definition and treatment of primary hyperhidrosis.

Authors:  Birgit Wörle; Stefan Rapprich; Marcy Heckmann
Journal:  J Dtsch Dermatol Ges       Date:  2007-07       Impact factor: 5.584

4.  Hyperhidrosis plantaris - a randomized, half-side trial for efficacy and safety of an antiperspirant containing different concentrations of aluminium chloride.

Authors:  Meike Streker; Tilmann Reuther; Linda Hagen; Martina Kerscher
Journal:  J Dtsch Dermatol Ges       Date:  2011-08-16       Impact factor: 5.584

5.  [Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis].

Authors:  M Streker; T Reuther; S Verst; M Kerscher
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

6.  Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution.

Authors:  E Hölzle; O Braun-Falco
Journal:  Br J Dermatol       Date:  1984-04       Impact factor: 9.302

7.  Antimicrobial effects of an antiperspirant formulation containing aqueous aluminum chloride hexahydrate.

Authors:  E Hölzle; U Neubert
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Aluminum chlorohydrate I: Structure studies.

Authors:  D L Teagarden; J F Kozlowski; J L White; S L Hem
Journal:  J Pharm Sci       Date:  1981-07       Impact factor: 3.534

Review 9.  [Current treatment of focal hyperhidrosis. Surgical approaches].

Authors:  F G Bechara
Journal:  Hautarzt       Date:  2009-07       Impact factor: 0.751

10.  Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.

Authors:  Falk G Bechara; Thilo Gambichler; Armin Bader; Michael Sand; Peter Altmeyer; Klaus Hoffmann
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

View more
  4 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 2.  [Topical therapy of inflammatory dermatoses, pruritus and pain, as well as hyperhidrosis].

Authors:  K Schultheis; A Messerschmidt; F Ochsendorf
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

3.  Transareolar single-port endoscopic thoracic sympathectomy with a flexible endoscope for primary palmar hyperhidrosis: a prospective randomized controlled trial.

Authors:  Jian-Bo Lin; Ming-Qiang Kang; Jian-Feng Chen; Quan Du; Xu Li; Fan-Cai Lai; Yuan-Rong Tu
Journal:  Ann Transl Med       Date:  2020-12

Review 4.  Dermatological problems of the puberty.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.